@article{d500a6a615b94b71a94a55848f3cf0fe,
title = "DNA Polymerase Epsilon Deficiency Causes IMAGe Syndrome with Variable Immunodeficiency",
abstract = "During genome replication, polymerase epsilon (Pol ε) acts as the major leading-strand DNA polymerase. Here we report the identification of biallelic mutations in POLE, encoding the Pol ε catalytic subunit POLE1, in 15 individuals from 12 families. Phenotypically, these individuals had clinical features closely resembling IMAGe syndrome (intrauterine growth restriction [IUGR], metaphyseal dysplasia, adrenal hypoplasia congenita, and genitourinary anomalies in males), a disorder previously associated with gain-of-function mutations in CDKN1C. POLE1-deficient individuals also exhibited distinctive facial features and variable immune dysfunction with evidence of lymphocyte deficiency. All subjects shared the same intronic variant (c.1686+32C>G) as part of a common haplotype, in combination with different loss-of-function variants in trans. The intronic variant alters splicing, and together the biallelic mutations lead to cellular deficiency of Pol ε and delayed S-phase progression. In summary, we establish POLE as a second gene in which mutations cause IMAGe syndrome. These findings add to a growing list of disorders due to mutations in DNA replication genes that manifest growth restriction alongside adrenal dysfunction and/or immunodeficiency, consolidating these as replisome phenotypes and highlighting a need for future studies to understand the tissue-specific development roles of the encoded proteins.",
keywords = "DNA replication, IMAGe syndrome, adrenal failure, cell cycle, growth, immunodeficiency, microcephaly, polymerase epsilon",
author = "{SGP Consortium} and Logan, {Clare V.} and Murray, {Jennie E.} and Parry, {David A.} and Andrea Robertson and Roberto Bellelli and {\v Z}ygimantė Tarnauskaitė and Rachel Challis and Louise Cleal and Valerie Borel and Adeline Fluteau and Javier Santoyo-Lopez and Aitman, {Timothy J.} and Biankin, {Andrew V.} and Cooke, {Susanna L.} and Humphrey, {Wendy Inglis} and Sancha Martin and Lynne Mennie and Alison Meynert and Zosia Miedzybrodzka and Fiona Murphy and Craig Nourse and Semple, {Colin A.} and Nicola Williams and Tim Aitman and In{\^e}s Barroso and Donald Basel and Bicknell, {Louise S.} and Himanshu Goel and Hao Hu and Chad Huff and Michele Hutchison and Caroline Joyce and Rachel Knox and Lacroix, {Amy E.} and Sylvie Langlois and Shawn McCandless and Julie McCarrier and Metcalfe, {Kay A.} and Rose Morrissey and Nuala Murphy and Ir{\`e}ne Netchine and O'Connell, {Susan M.} and Olney, {Ann Haskins} and Nandina Paria and Rosenfeld, {Jill A.} and Mark Sherlock and Erin Syverson and White, {Perrin C.} and Carol Wise and Yao Yu",
note = "Funding Information: We thank the families and clinicians for their involvement and participation; the Potentials Foundation and Walking with Giants Foundation; D. Fitzpatrick, N. Hastie, and W. Bickmore for discussions; E. Freyer for assistance with FACS analysis; IGMM core sequencing service; and Edinburgh Genomics (Clinical Division) for WGS sequencing. We thank Penny Jeggo for sharing cell lines. This work was supported by funding to the Jackson lab from European Research Council ERC Starter Grant HumGenSize, 281847 ; ERC Advanced Investigator Grant GrowCell, 788093 ; by a UK Medical Research Council Human Genetics Unit core grant (MRC, U127580972 ), and the Scottish Genomes Partnership . The Rios lab is supported by Texas Scottish Rite Hospital for Children and the Children{\textquoteright}s Medical Center Foundation . Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR001105 . The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Boulton lab work is supported by the Francis Crick Institute , which receives its core funding from Cancer Research UK ( FC0010048 ), the UK Medical Research Council ( FC0010048 ), and the Wellcome Trust ( FC0010048 ); a European Research Council (ERC) Advanced Investigator Grant ( TelMetab ); and Wellcome Trust Senior Investigator and Collaborative Grants . R.K.S. is funded by the Wellcome Trust ( 210752/Z/18/Z ). The Scottish Genomes Partnership is funded by the Chief Scientist Office of the Scottish Government Health Directorate s ( SGP/1 ) and The Medical Research Council Whole Genome Sequencing for Health and Wealth Initiative . Publisher Copyright: {\textcopyright} 2018 The Authors",
year = "2018",
month = dec,
day = "6",
doi = "10.1016/j.ajhg.2018.10.024",
language = "English (US)",
volume = "103",
pages = "1038--1044",
journal = "American Journal of Human Genetics",
issn = "0002-9297",
publisher = "Cell Press",
number = "6",
}